Exelixis reported $272.74M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 228.48M 53.07M
Agios Pharmaceuticals AGIO:US $ 99.27M 2.91M
Akebia Therapeutics AKBA:US $ 120.19M 5.57M
Amgen AMGN:US $ 3.74B 804M
AstraZeneca AZN:LN 10.51B 1.79B
Bayer BAYN:GR 10.43B 1.33B
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Bluebird Bio BLUE:US $ 122.29M 14.98M
Bristol Myers Squibb BMY:US $ 9.1B 247M
Cytokinetics CYTK:US $ 81.7M 4.39M
Eisai 4523:JP Y 211704M 22380M
Eli Lilly And LLY:US $ 5405.7M 677M
Esperion Therapeutics ESPR:US $ 61.82M 9.2M
Exelixis EXEL:US $ 272.74M 61.76M
Genmab GEN:DC 1.61B 205M
Glaxosmithkline GSK:US 6.98B 1.65B
Immunogen IMGN:US $ 60.93M 1.62M
Merk MRK:US $ 10332M 386M
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Moderna Inc MRNA:US 1.84B 38M
Nektar Therapeutics NKTR:US $ 137.92M 598K
Novartis NOVN:VX 9.96B 998M
Puma Biotechnology PBYI:US $ 46.5M 1.83M
Seattle Genetics SGEN:US $ 559.51M 42.41M
Takeda 4502:JP 874.91B 90.1B
Ultragenyx Pharmaceutical RARE:US $ 216.57M 30.61M
Xencor XNCR:US $ 59.03M 3.13M
YTE INCY:US $ 616.69M 135.42M